Intrarosa (prasterone) was recently FDA approved to treat moderate to severe painful sexual intercourse (dyspareunia) caused by vulvar and vaginal atrophy (VVA). VVA is a common condition affecting up to 50% of postmenopausal women that results from the loss of estrogen during menopause. This causes the walls of the vagina and surrounding tissues to become … Read more

On July 24th, 2018 the US Food and Drug Administration (FDA) approved Elagolix for the treatment of moderate to severe pain associated with endometriosis. Dr. Robin Kroll, director of Seattle Clinical Research Center has conducted over a dozen clinical trials with the newly approved endometriosis treatment, Orilissa. The drug, Elagolix — now marketed as Orilissa … Read more

This month, Flibanserin, commonly referred to as “female Viagra,” goes to the full Food and Drug Administration for a vote of approval. In early June, a federal advisory committee to the FDA recommended approval. The final vote is due on or before August 18. The entire concept of Female Sexual Dysfunction (FSD) is controversial. Does … Read more

The Cancer Risk Awareness Survey, conducted by the American Institute for Cancer Research (referenced here), demonstrates that we Americans aren’t always aware of things that have been proven to decrease our risk of cancer, and sometimes do things we think decrease our risk of cancer, but have not been proven to do so. But they neglect to mention a very … Read more

Birth control pills were first released in the 1960s, and since then the variety and choice in contraception has only expanded. Picking what’s right for you can be a bit overwhelming and confusing, but at Seattle Clinical Research Center we want you to be informed so we’ve put together a brief summary of the popular … Read more